Pancreatic neuroendocrine tumors (PNET) comprise up to 10% of all pancreatic solid tumors. There has been much interest in recent years with regards to the role of limited resection and enucleation procedures for this entity. There is no clear guideline today on the optimal type choice of surgery for this condition, with even fewer reporting on the use of a robotic approach for pancreatic uncinate lesions. We describe a case report of a 54-year-old lady who underwent successful robotic enucleation of pancreatic uncinate neuroendocrine tumor. This patient's recovery was complicated by pancreatitis and a peripancreatic collection, both of which resolved without surgical re-intervention. A literature review was performed with regards to current guidelines on management of PNETs, comparisons between demolitive and parenchymal-preserving procedures, and recent developments in the laparoscopic and robotic approaches for this condition. There is no clear guideline on the optimal type and approach (open vs. laparoscopic vs. robotic) to the surgical management of PNET. We document in this case report a novel approach of robotic enucleation of pancreatic uncinate process NET, that could be considered as an alternative to open/laparoscopic demolitive procedures for small uncinate tumors. (Ann Hepatobiliary Pancreat Surg 2020;24:97-103)
INTRODUCTION
OS as compared to demolitive procedures, the vast majority of reviews report no significant differences. 1, [9] [10] [11] Most recent NCCN guidelines report benign tumors, isolated lesions, distance between tumor and MPD ＞3 mm with no focal stricture or dilatation, insulinomas and gastrinomas ＜2 cm in size, and NF-PNETs ＜2 cm in size with low Ki-67 and mitotic indices as indications for EN procedure. 7 For the group of F-PNETs, EN is advocated only for insulinomas, given the higher risk of lymph node metastasis and locoregional involvement associated with other F-PNET subtypes. 6 Strict adherence to the size criteria for NF-PNETs is strongly advocated in this study, given the undoubted correlation between tumor size and risk of malignancy and metastasis. 7 A common consensus of current data suggests that an EN approach is feasible only for small (＜2 cm), low grade, superficial NF-PNETs. 1, 8, 10 With appropriate selection criteria applied, EN has been shown to have superior perioperative outcomes (operative times, blood loss, adverse events according to Clavien-Dindo grading), and an equivalent DFS and OS when compared to demolitive procedures. 1, [9] [10] [11] [12] One major drawback of EN is its consistently significant correlation with higher rates of post-operative pancreatic fistu- In comparing open and minimally invasive (MIS) approaches to PNET surgery, the latter has been reported to be non-inferior, and significantly associated with shorter operative time, lower morbidity and POPF rates, and decreased duration of hospital stay. [12] [13] [14] To date there exist only two meta-analyses specific to the comparison be- higher rates of splenic preservation, reduced length of hospital stay and quicker return to activities. 12, [16] [17] [18] [19] Most studies now report comparable results between robotic and laparoscopic surgery with regards to both peri-operative, long-term and oncological outcomes. 12, [17] [18] [19] It is however widely recognized that there is an overall lack of statisti- approach. In addition, this study found that robotic surgery reduced the duration of surgery and blood loss. 18 Zhang et al. 19 is one of few to have reported on comparisons between robotic and laparoscopic pancreatectomies for PNETs. This study found the robotic approach to be superior with regards to less blood loss, higher rates of splenic preservation and more lymph node harvest. Gene-www.ahbps.org ralizability is however limited, given that this study only included patients undergoing distal pancreatectomies. 19 Machado et al. 20 reported in November 2018 the first case of robotic resection of pancreatic uncinate process for PNET. The distance between tumor and MPD was 4 mm and this patient had no post-operative complications. 20 To our knowledge, this is the second report of a robotic enucleation of a pancreatic uncinate NET in the current literature. Although the surgical procedure proceeded smoothly with no major intraoperative adverse events and minimal blood loss, the patient's postoperative recovery was complicated by the development of POPF with a symptomatic intra-abdominal collection requiring percutaneous drainage. This in our opinion was not surprising as EN is well-known to be associated with a high rate of POPF of over 50% especially when the tumor is deepseated and located close to the MPD. 11, 12, 14 Nonetheless, it is important to note that despite the potentially higher postoperative morbidity rate especially with regard to the POPF associated with EN compared to pancreaticoduodenectomy, the incidence of life-threatening POPF such as bleeding from pseudoaneurysm is frequently lower with EN. This has been postulated to be due to the absence of activated pancreatic juice after EN compared to that after pancreaticoduodenectomy whereby the pancreatic fluid has been mixed with and potentially activated by enteric contents. Moreover, pancreaticoduodenectomy when performed for PNET is well-known to be associated with a higher rate of clinically-significant POPF compared to that for ductal adenocarcinoma due to the presence of a small non-dilated pancreatic duct and soft pancreas. 12 Hence, when considering performing EN for uncinate tumors, one should carefully consider the technical challenges of this rare and novel procedure especially via the minimally-invasive approach, combined with the increased incidence of POPF versus the more severe morbidity, mortality and long-term consequences associated with pancreaticoduodenectomy. More comparative studies in larger patient cohorts are needed to determine if EN is a safe and effective alternative parenchymal-saving surgical strategy for small benign and premalignant tumors located in the uncinate process.
CONCLUSION
We report a novel case of successful robotic enucleation of pancreatic uncinate process NET. This surgical strategy may be considered as an alternative pancreatic parenchymal-saving approach to pancreatoduodenectomy for small benign tumors in the pancreatic uncinate process. However, further studies are needed to confirm the feasibility and safety of this rare technically-demanding procedure especially when performed via the minimallyinvasive approach.
